This content is machine translated GLP-1 receptor agonists (GLP-1-RA) Type 2 diabetics benefit from dulaglutide in several ways The ADA/EASD guidelines recommend individualized therapy choices for type 2 diabetics. GLP-1 receptor agonists not only improve glycemic control, but also support weight loss, reduce the risk of cardiovascular disease,…
View Post 5 min This content is machine translated Corona pandemic Diabetes patients with COVID-19: current expert assessment. Poorly controlled diabetes is a risk factor for severe COVID-19 progression. Therefore, especially during the corona pandemic, the best possible blood glucose control is crucial. However, it has been shown…
View Post 16 min This content is machine translated Type 2 diabetes The cardiovascular diabetic patient – an interdisciplinary challenge A patient with type 2 diabetes is 2-3 times more likely to have a myocardial infarction or stroke than people without diabetes. Cardiovascular disease accounts for up to 50% of… CME-Test
View Post 10 min This content is machine translated Chronic inflammatory bowel disease (CED) Modern “State-of-the-Art” Pharmacotherapy – an Update Modern approaches to the treatment of inflammatory bowel disease (IBD) are based on the motto “treat-to-target”, whereby in addition to symptom relief and induction of disease remission, the aim nowadays… CME-Test
View Post 3 min This content is machine translated Diabetes Management Type 1 diabetics benefit from additive oral therapy Type 1 diabetics with obesity in whom insulin therapy alone is insufficient for glycemic control may additionally benefit from oral treatment with an SGLT2 inhibitor. Recent study results show good…
View Post 4 min This content is machine translated Diabetes Cases Intensification of the treatment of type 2 diabetes mellitus In a 63-year-old patient, although glucose metabolic control is quite good, there is still potential for optimizing diabetes management. Thus, with a change in therapy, his pre-existing cardiovascular conditions can…
View Post 4 min This content is machine translated SGLT-2 inhibitors and GLP-1-RA How they can protect against diabetic sequelae In recent years, numerous new glucose-lowering agents have been developed. SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular and nephroprotective effects in large clinical endpoint studies. The variety of…
View Post 4 min This content is machine translated Undifferentiated rheumatoid arthritis Early detection as the basis for adequate therapy In the case of arthritic complaints, regular progress assessment using the ACR/EULAR criteria is significant so that the time for disease-modifying therapy is not missed. Controlling disease activity at an…
View Post 3 min This content is machine translated Diabetes Cases Type 2 diabetes mellitus and advanced renal failure A 73-year-old female patient who has had type 2 diabetes mellitus for 10 years is unhappy with her weight and needs improved glycemic control. However, macronutrient malnutrition combined with advanced…
View Post 1 min This content is machine translated IBD matters State of the art in IBD treatment The classic symptoms of inflammatory bowel disease (IBD) range from mild abdominal pain to colicky symptoms and persistent diarrhea. Phases of low disease activity may be followed by severe episodes.…
View Post 6 min This content is machine translated Diabetes treatment Insulin therapy in type 2 diabetics: an update. The most modern representatives of basal insulins are ultra-long acting and associated with low hypoglycemia rates. Mixed insulin or combination preparations of GLP-1-RA and a long-acting insulin are good alternatives…
